These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2139850)

  • 1. Survival of islet isografts despite cytotoxicity against pancreatic islets measured in vitro.
    Ziegler B; Köhler E; Klöting I; Besch W; Ziegler M
    Exp Clin Endocrinol; 1990 Feb; 95(1):31-8. PubMed ID: 2139850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic control of diabetes induction by complete Freund's adjuvant combined with subdiabetogenic doses of streptozotocin in Lewis rats--evidence for transient cytotoxicity against beta cells.
    Ziegler B; Tietz S; Kohnert KD; Köhler E; Knospe S; Klöting I; Ziegler M
    Exp Clin Endocrinol; 1987 Aug; 89(3):269-75. PubMed ID: 2959492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Destruction of pancreatic beta cells in rats by complete Freund's adjuvant combined with non-diabetogenic doses of streptozotocin.
    Kohnert KD; Odselius R; Fält K; Ziegler B; Ziegler M; Falkmer S
    Diabetes Res; 1987 May; 5(1):1-11. PubMed ID: 2957141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune response directed to pancreatic beta cells in rats induced by combined treatment with low doses of streptozotocin and complete Freund's adjuvant.
    Ziegler M; Ziegler B; Hehmke B; Dietz H; Hildmann W; Kauert C
    Biomed Biochim Acta; 1984; 43(5):675-81. PubMed ID: 6236801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical, immunohistochemical and ultrastructural studies of the alteration of pancreatic beta cells resulting from the combined effects of complete Freund's adjuvant and non-diabetogenic doses of streptozotocin.
    Kohnert KD; Ziegler B; Fält K; Odselius R; Ziegler M; Falkmer S
    Exp Clin Endocrinol; 1987 Aug; 89(3):259-68. PubMed ID: 2959491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta cell destruction of pancreatic islets transplanted into diabetic BB/OK rats may be reflected by increased antibody-mediated anti-islet cytotoxicity.
    Schröder D; Wanka H; Hehmke B; Klöting I; Köhler E; Knospe S; Schmidt S
    Diabetes Res; 1990 Sep; 15(1):27-32. PubMed ID: 2132197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic control of susceptibility to severe hyperglycaemia evoked by CFA/SZ-induced immune response against beta cells in various rat strains.
    Ziegler M; Ziegler B; Kohnert KD; Klöting I
    Biomed Biochim Acta; 1988; 47(4-5):337-42. PubMed ID: 2977097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
    Sternesjö J; Welsh N; Sandler S
    Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathological lesions in the pancreas of a rat model of diabetes induced with complete Freund's adjuvant and low-dose streptozotocin.
    Kohnert KD; Fält K; Ziegler B; Odselius R; Ziegler M; Falkmer S
    Exp Clin Endocrinol; 1990 Feb; 95(1):47-56. PubMed ID: 2139852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and immune response to islet antigens following treatment with low doses of streptozotocin in H-2d mice.
    Herold KC; Baumann E; Vezys V; Buckingham F
    J Autoimmun; 1997 Feb; 10(1):17-25. PubMed ID: 9080296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and time course of humoral-mediated cytotoxicity to different cell types in diabetes-prone BB/OK rats.
    Schröder D; Hehmke B; Klöting I; Schmidt S
    Diabetes Res; 1991 Jun; 17(2):81-91. PubMed ID: 1817815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silica prevents the induction of diabetes with complete Freund's adjuvant and low-dose streptozotocin in rats.
    Wright JR; Lacy PE
    Diabetes Res; 1989 Jun; 11(2):51-4. PubMed ID: 2559826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection.
    Callewaert HI; Gysemans CA; Ladrière L; D'Hertog W; Hagenbrock J; Overbergh L; Eizirik DL; Mathieu C
    Diabetes; 2007 Aug; 56(8):2169-73. PubMed ID: 17473223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo behaviour of rat islets of Langerhans treated with MHC antisera and complement.
    Kuttler B; Schmidt S; Klöting I; Stark O
    Exp Clin Endocrinol; 1987 Aug; 89(3):283-9. PubMed ID: 3117579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-mediated immune reactions against islets of Langerhans in diabetes-prone BB rats.
    Knospe S; Köhler E; Klöting I
    Exp Clin Endocrinol; 1987 Aug; 89(3):290-6. PubMed ID: 3311775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment of rat pancreatic islets with MHC I-A monoclonal antibody: in-vitro and in-vivo effects on islet antigenicity.
    Flesch BK; Bretzel RG; Otto DA; Ernst-Schlegel M; Federlin K
    Horm Metab Res; 1991 Aug; 23(8):357-61. PubMed ID: 1794836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surviving native beta-cells determine outcome of syngeneic intraportal islet transplantation.
    Hughes SJ; Powis SH; Press M
    Cell Transplant; 2001; 10(2):145-51. PubMed ID: 11332628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose and ATP levels in pancreatic islet tissue of normal and diabetic rats.
    Matschinsky FM; Pagliara AS; Stillings SN; Hover BA
    J Clin Invest; 1976 Nov; 58(5):1193-200. PubMed ID: 136453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1beta and inducible form of nitric oxide synthase expression in early syngeneic islet transplantation.
    Montolio M; Biarnés M; Téllez N; Escoriza J; Soler J; Montanya E
    J Endocrinol; 2007 Jan; 192(1):169-77. PubMed ID: 17210754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of antibodies to islet cell and splenic lymphocytes in diabetes-prone BB and adjuvant-streptozotocin treated Lewis rats by ELISA and immunoblot analysis.
    Kohnert KD; Besch W; Schröder D; Ziegler B; Hehmke B; Fält K; Ziegler M
    Allerg Immunol (Leipz); 1990; 36(4):321-31. PubMed ID: 2097900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.